China Chemical & Pharmaceutical Co Ltd (1701):企業の財務・戦略的SWOT分析

◆英語タイトル:China Chemical & Pharmaceutical Co Ltd (1701) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2909
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥17,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥51,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

China Chemical & Pharmaceutical Co Ltd (1701) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

China Chemical & Pharmaceutical Co Ltd (CCPC) is a pharmaceutical company which carries out research and development and contract manufacturing of pharmaceutical products for human and animal healthcare. CCPC manufactures prescription and over-the-counter (OTC) drugs that focus on the treatment of chronic cardiovascular diseases and metabolic disorders, acute infections, psychiatric disorders, allergies and respiratory disorders. It also manufactures animal drugs, non-medical feed additives and health foods those for poultry, pigs, cows and companion animals. The company partners with animal drugs distributors in China to market its niche products in the Chinese market. CCPC is headquartered at Taipei, Taiwan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
China Chemical & Pharmaceutical Co Ltd – Key Facts 5
China Chemical & Pharmaceutical Co Ltd – Key Employees 6
China Chemical & Pharmaceutical Co Ltd – Major Products and Services 7
China Chemical & Pharmaceutical Co Ltd – History 9
China Chemical & Pharmaceutical Co Ltd – Company Statement 10
China Chemical & Pharmaceutical Co Ltd – Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 – Company Analysis 13
Company Overview 13
China Chemical & Pharmaceutical Co Ltd – Business Description 14
China Chemical & Pharmaceutical Co Ltd – SWOT Analysis 15
SWOT Analysis – Overview 15
China Chemical & Pharmaceutical Co Ltd – Strengths 15
China Chemical & Pharmaceutical Co Ltd – Weaknesses 17
China Chemical & Pharmaceutical Co Ltd – Opportunities 18
China Chemical & Pharmaceutical Co Ltd – Threats 19
China Chemical & Pharmaceutical Co Ltd – Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios – Capital Market Ratios 21
Financial Ratios – Annual Ratios 22
Performance Chart 25
Financial Performance 25
Financial Ratios – Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
China Chemical & Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
China Chemical & Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
China Chemical & Pharmaceutical Co Ltd, Recent Deals Summary 29
Section 5 – Appendix 30
Methodology 30
Ratio Definitions 30
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
China Chemical & Pharmaceutical Co Ltd, Key Facts 5
China Chemical & Pharmaceutical Co Ltd, Key Employees 6
China Chemical & Pharmaceutical Co Ltd, Major Products and Services 7
China Chemical & Pharmaceutical Co Ltd, History 9
China Chemical & Pharmaceutical Co Ltd, Other Locations 11
China Chemical & Pharmaceutical Co Ltd, Subsidiaries 12
China Chemical & Pharmaceutical Co Ltd, Key Competitors 20
China Chemical & Pharmaceutical Co Ltd, Ratios based on current share price 21
China Chemical & Pharmaceutical Co Ltd, Annual Ratios 22
China Chemical & Pharmaceutical Co Ltd, Annual Ratios (Cont...1) 23
China Chemical & Pharmaceutical Co Ltd, Annual Ratios (Cont...2) 24
China Chemical & Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
China Chemical & Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
China Chemical & Pharmaceutical Co Ltd, Recent Deals Summary 29
Currency Codes 30
Capital Market Ratios 30
Equity Ratios 31
Profitability Ratios 31
Cost Ratios 32
Liquidity Ratios 32
Leverage Ratios 33
Efficiency Ratios 33

List of Figures
China Chemical & Pharmaceutical Co Ltd, Performance Chart (2013 - 2017) 25
China Chemical & Pharmaceutical Co Ltd, Ratio Charts 26
China Chemical & Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
China Chemical & Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

★海外企業調査レポート[China Chemical & Pharmaceutical Co Ltd (1701):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Choice Hotels International Inc:戦略・SWOT・企業財務分析
    Choice Hotels International Inc - Strategy, SWOT and Corporate Finance Report Summary Choice Hotels International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Gruma, S.A.B. de C.V.:企業の戦略・SWOT・財務情報
    Gruma, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Gruma, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Investigator Resources Ltd (IVR):企業の財務・戦略的SWOT分析
    Summary Investigator Resources Ltd (Investigator Resources), formerly Southern Uranium Ltd, is a mining company that offers exploration and development of mineral properties. The company acquires, explores and develops precious and base metal assets in Eyre Peninsulas of South Australia. It operates …
  • Pure Technologies Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Pure Technologies Ltd. (Pure Technologies) develops technologies for inspection, monitoring and management of physical infrastructure such as buildings, water and hydrocarbon pipelines, and bridges. It provides proprietary monitoring equipment for pipelines, bridges and structures; technical …
  • Bartlett Cocke General Contractors:企業の戦略・SWOT・財務情報
    Bartlett Cocke General Contractors - Strategy, SWOT and Corporate Finance Report Summary Bartlett Cocke General Contractors - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • EFU Life Assurance Ltd.:企業の戦略・SWOT・財務情報
    EFU Life Assurance Ltd. - Strategy, SWOT and Corporate Finance Report Summary EFU Life Assurance Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Synchrony Financial:企業の戦略・SWOT・財務分析
    Synchrony Financial - Strategy, SWOT and Corporate Finance Report Summary Synchrony Financial - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sopheon Plc:企業の戦略・SWOT・財務情報
    Sopheon Plc - Strategy, SWOT and Corporate Finance Report Summary Sopheon Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Affimed GmbH (AFMD):企業の財務・戦略的SWOT分析
    Summary Affimed GmbH (Affimed), formerly Affimed Therapeutics AG, a subsidiary of Affimed NV, is a clinical stage biopharmaceutical company which discovers and develops targeted cancer immunotherapies. The company’s pipeline product candidates include AFM11, AFM12, AFM13, AFM21 and AFM22, among othe …
  • Neon Therapeutics Inc (NTGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Neon Therapeutics Inc (Neon Therapeutics) is a clinical-stage immuno-oncology company that focuses on the development of neoantigen-based therapeutics for the treatment of cancer. The company pipeline product portfolio comprises NEO-PV-01, a personal neoantigen vaccine; NEO-PTC-01, a persona …
  • Verizon Communications Inc.:企業のM&A・事業提携・投資動向
    Verizon Communications Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Verizon Communications Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • NextEra Energy Inc (NEE):石油・ガス:M&Aディール及び事業提携情報
    Summary NextEra Energy, Inc. (NEE), formerly FPL Group, Inc., is an electric power and energy infrastructure company that generates, transmits and distributes electricity together with its subsidiaries. The company generates power through various sources such as nuclear, coal, oil and natural gas-fi …
  • Human Stem Cells Institute (ISKJ):企業の財務・戦略的SWOT分析
    Summary Human Stem Cells Institute (HSCI) is a biotech company that provides discovery, research and development, and marketing of proprietary products and services in the areas of regenerative medicine, medical genetics, bio-insurance, gene therapy and biopharmaceutics. The company offers neovascul …
  • Moody’s Corporation:企業の戦略・SWOT・財務情報
    Moody's Corporation - Strategy, SWOT and Corporate Finance Report Summary Moody's Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Celulose Irani S.A.:企業の戦略・SWOT・財務情報
    Celulose Irani S.A. - Strategy, SWOT and Corporate Finance Report Summary Celulose Irani S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Gerdau S.A.:戦略・SWOT・企業財務分析
    Gerdau S.A. - Strategy, SWOT and Corporate Finance Report Summary Gerdau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Illumina Inc (ILMN):医療機器:M&Aディール及び事業提携情報
    Summary Illumina Inc (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; microar …
  • Valeo Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Valeo Pharma Inc (Valeo Pharma), a subsidiary of Manitex Capital Inc, is a pharmaceutical company that offers healthcare solutions and specialty products. The company provides dermatology products such as drops, tablets, solutions, injections among others. It develops, licenses, and commerci …
  • Industrial Development Company s.a.l.:企業の戦略・SWOT・財務分析
    Industrial Development Company s.a.l. - Strategy, SWOT and Corporate Finance Report Summary Industrial Development Company s.a.l. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Bio-Modeling Systems SAS-製薬・医療分野:企業M&A・提携分析
    Summary Bio-Modeling Systems SAS (BM Systems) is a mechanism based medicine company which discovers and develops novel diagnostic, therapeutic and prevention solutions. The company owns an operational mechanisms-based medicine platform known as Computer-Assisted Deductive Integration (CADI), which i …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆